23andMe Is Going Public Via a SPAC. Here's What You Need to Know

With the power of DNA sequencing technology, all it takes is spitting in a tube to answer these (not at all) equally important questions. You can't just spit into any old tube, of course -- you'll need to use a sample collection vial from a genetic testing company like 23andMe. As part of its plan to expand its growth potential and become a leader in genomic data-driven drug discovery, 23andMe announced this week that it will go public by merging with VG Acquisition Corporation (NYSE: VGAC.U) sometime in the second quarter.